Pulmonary hypertension associated with congenital cardiac disease

Cardiology in the Young

Volumn 19, Issue 4, 2009, Pages 311-314

  Berger, Rolf M F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Advanced therapies; Clinical trial; Eisenmenger syndrome; Evidence based; Systemic to pulmonary shunts

Indexed keywords

BOSENTAN; PLACEBO;

CLINICAL TRIAL; CONGENITAL HEART DISEASE; CYANOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; EISENMENGER COMPLEX; EVIDENCE BASED MEDICINE; HEART HEMODYNAMICS; HEART LEFT RIGHT SHUNT; HEMATOLOGIC DISEASE; HUMAN; LIFESTYLE MODIFICATION; ONSET AGE; PALLIATIVE THERAPY; PULMONARY HYPERTENSION;

DISEASE PROGRESSION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY;

EID: 70349196335     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951109990138     Document Type: Editorial

References (9)

1. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30: 104-109.
2. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 5S-12S.
3. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009; 30: 394-403.
4. Duffels MG, Engelfriet PM, Berger RMF, van Loon RL, Hoendermis E, Vriend JW, van der Velde ET, Bresser P, Mulder BJ. Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry. Int J Cardiol 2007; 120: 198-204.
5. Engelfriet PM, Duffels MG, Moller T, Boersma E, Tijssen JG, Thaulow E, Gatzoulis MA, Mulder BJ. Pulmonary arterial hypertension in adults born with a heart septal defect: The Euro Heart Survey on adult congenital heart disease. Heart 2007; 93: 682-687.
6. van Albada ME, Berger RMF. Pulmonary arterial hypertension in congenital cardiac disease-the need for refinement of the Evian-Venice classification. Cardiol Young 2008; 18: 10-17.
7. Berger RMF. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 2000; 21: 17-27.
8. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RMF, Lauer A, Chiossi E, Landzberg M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Bosentan therapy in patients with Eisenmenger syndrome: A multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006; 114: 48-54.
9. Lopes AA, Rabinovitch M. Statements on the management of pulmonary hypertension associated with congenital heart disease. Cardiol Young 2009; E-Supplement 1: 1-53.